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Abstract
Vitek Tracz and Rebecca Lawrence declare the current journal publishing
system to be broken beyond repair. They propose that it should be replaced
by immediate publication followed by transparent peer review as the
starting place for more open and efficient reporting of science. While
supporting this general objective, we suggest that research is needed both
to understand why biomedical scientists have been slow to take up preprint
options, as well as to assess the relative merits of this and other
alternatives to journal publishing.
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Editorial
Vitek Tracz (Chairman of F1000, which includes F1000Research) 
and Rebecca Lawrence (Managing Director of F1000) declare 
the current journal publishing system to be broken beyond repair 
(Tracz & Lawrence, 2016). They propose much greater use of 
immediate publication of articles as the starting place for open, 
interactive dialogues between study authors and commentators 
on reports of research (whether or not commentators are desig-
nated formally as ‘peer reviewers’). Logically, over the course of 
one or more iterations, this interaction should promote the evolu-
tion of more ‘stable’, trustworthy and useful records of research. 
Furthermore, new technology provides a much more efficient 
system for dealing with submitted reports of research than that 
offered by most current journals using traditional forms of peer-
review.
As Tracz and Lawrence recognise, although the use of preprints 
for reporting research was introduced by particle physicists decades 
ago, it has not attracted much tangible support from life scientists. 
Why is this; and what might be the downsides of their proposed 
preprint-led revolution?
Part of the explanation seems likely to reflect reasonable concern 
about the danger that preprints reporting flawed research may 
prompt unwarranted changes in clinical practice that harm patients. 
Tabor (2016), commenting on a recent call for a prepublication 
culture in clinical research like that established in some areas of 
physics (Lauer et al., 2015), noted that “clinical studies of poor 
quality can harm patients who might start or stop therapy in response 
to faulty data, whereas little short-term harm would be expected 
from an unreviewed astronomy study”.
Reasonable people can identify with this concern about the potential 
dangers of an increased use of preprints in biomedicine. However, 
other reasons for the poor uptake of preprint opportunities seem 
likely to reflect less worthy, often perverse interests, reflecting finan-
cial or academic conflicts, or just acquiescence in sloppy science.
Despite their recognition of the increasingly acknowledged impor-
tance of collaboration, the model proposed by Tracz and Lawrence 
focuses on “individual researcher’s scientific output”, and they 
believe that the model they propose would work only if driven 
by authors “within a scientific framework that facilitates self- 
regulation”. This judgement ignores the abundant evidence that 
self-regulation by researchers cannot alone deal adequately with 
many of the systemic problems apart from journals which are lead-
ing to waste, bad science, bad ethics and harm to patients.
Although Tracz and Lawrence introduce their proposals with an 
allusion to “the need to remove the waste in the current system”, 
they don’t address sources of research waste other than current 
publishing processes, such as waste resulting from avoidable design 
flaws, and incomplete or misleading reporting (www.rewardal-
liance.net; Paul Glasziou and Iain Chalmers: Is 85% of health 
research really “wasted”?). The most clearcut example of these sys-
temic problems is biased underreporting of research, with around 
half of all research going unpublished, implying $10s of billions 
wasted yearly.
Although underreporting can cause avoidable suffering and death, 
appeals to the biomedical research community beginning in the 
mid-1980s to deal with the problem had no discernible impact until 
this century (https://clinicaltrials.gov/ct2/resources/trends). Change 
began when the International Committee of Medical Journal 
Editors required researchers to register controlled trials at inception 
(for example, at www.clinicaltrials.gov and www.isrctn.com), fol-
lowed by the substantial community awareness of the scandal which 
followed publication of Ben Goldacre’s popular science book Bad 
Pharma and the launch of the AllTrials campaign (www.alltrials.net). 
After these direct appeals to the public to call the research com-
munity to account, increasing numbers of research funders and 
regulators began to require researchers to behave more responsi-
bly (Moher et al., 2015). But public recognition that self-regulation 
by researchers has failed has led to eroded trust in the biomedical 
research enterprise more generally.
As far as reporting of clinical trials is concerned, there has been slow 
progress towards the ideal of ‘threaded documents’, beginning with 
publication of the protocol, later publication of summary results, 
and going through to deposition of the final dataset (Chalmers & 
Altman, 1999). But post-publication corrections, updates, simple 
linkages to similar studies and systematic reviews are also impor-
tant for those trying to use, apply, or replicate studies.
We know remarkably little, formally, about why researchers do and 
don’t do the things that they do and don’t do. Some efforts to secure 
research funding to investigate why researchers don’t publish reports 
of their research have not been successful (Professor Mary Dixon-
Woods, personal communication). If the attractive vision of a more 
efficient publishing model for the life sciences is to be promoted 
effectively, research is needed to find answers to the questions raised 
by Tracz and Lawrence themselves: why are researchers reluctant to 
post preprints, and will sufficient other researchers post useful and 
critical comments on them to make the effort worthwhile?
The current journal-based publication system is one of the impor-
tant weak links leading to current waste from non-reporting and 
poor reporting of research. There is no doubt that new models are 
needed, but these publishing experiments also warrant formal eval-
uation and comparison to assess which of them delivers most effec-
tively the advances needed. As far as clinical trials are concerned, 
methods and summary results are increasingly being posted on trials 
registries. More broadly, the National Institute for Health Research 
in England now requires publication of detailed reports for all the 
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health technology assessments it supports. Among journals, PLOS 
One’s decisions to publish a report are now based on whether the 
research has used valid methods, regardless of the results.
Tracz and Lawrence and F1000 are well placed to foster the explor-
atory and evaluative research needed to inform future developments 
in science publishing, and we very much hope they will do so.
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